Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.
about
Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular PathologyImaging of small animal peripheral artery disease models: recent advancements and translational potentialSPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular diseaseImproving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound.Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.Molecular imaging in cardiovascular disease: Which methods, which diseases?Oncologic Angiogenesis Imaging in the clinic---how and why.Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation.Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.Targeted molecular imaging of angiogenesis in PET and SPECT: a review.Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis.Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET.Advances in radionuclide molecular imaging in myocardial biology.Non-invasive Monitoring of Angiogenesis in Cardiology.A molecular imaging primer: modalities, imaging agents, and applications.Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2.Point: exercise training does induce vascular adaptations beyond the active muscle beds.Imaging stem cell therapy for the treatment of peripheral arterial disease.In vivo monitoring of angiogenesis in a mouse hindlimb ischemia model using fluorescent peptide-based probes.ImmunoPET of CD146 in a Murine Hindlimb Ischemia ModelEarly prediction of revascularisation by angiomotin-targeting positron emission tomography
P2860
Q26747500-05B83473-4B3F-45A3-A46A-2FCB117C0DDCQ27009178-89ADB577-9F48-492C-9928-2E79923000C8Q28066121-69B572BE-5F01-419F-9C00-4D8107107AFDQ30363630-5B5E441D-4F53-4923-9296-B80A19FAC944Q30413823-4E638B2D-49D9-4421-AA25-C9C624E52FE1Q30442045-F5ADB360-991C-452F-8CB1-78DA556361B7Q30472751-D0E8DA2A-C5D0-4FF1-B759-AEA82FDC5AC5Q33637137-4CC06201-4F4B-48A0-8158-5B3451180033Q34033191-9A175925-0DA1-4444-A18F-EE8E5C1D21ACQ34050525-DE329A51-76C3-438C-8918-A7092F424E2DQ34216877-BB627138-FEA1-4CC9-8264-4F4BC1D1645FQ34464099-E6959B21-49F0-4AB4-A5F1-01F8B4E7F9AEQ34759659-775A2C74-4E51-490B-A833-D36A6DD7A762Q35071225-3949D16A-259C-4ECB-873E-94E72E927EDAQ35646547-43C525D9-DEE8-433A-A61A-5E48277B9772Q35855490-D3D1027F-BDA5-42C2-A30B-BA30185A3520Q36193664-D743B3E9-D4A4-4BD3-89A1-4117E43715B4Q36307762-3AB620D7-6FBB-4603-BB0E-C50A28B745EAQ36322895-1AFEDA66-232B-4F3D-9E63-52DA1ED1E2E9Q36777298-33036A05-1300-4666-A11E-CFADD2CF3A6FQ37655420-95E05C22-0C86-4244-9370-10BC47391800Q37761310-4F4C38C2-6B55-49ED-B556-DA0D2A3ECFC0Q38005672-17FA4A77-5445-4BF2-BA77-27C91B5D396EQ38859160-883B8780-0300-4B07-A7A7-E61C354AB57CQ39253910-F6E94FC4-BB05-44E1-82E6-0BFB5D0A0EBDQ39809361-599EB1AB-19E3-44E5-844F-753DE62B709AQ50634935-BB59FEC7-6DB2-4217-B755-AE19B27D5517Q50666246-6B772EF5-C37D-4CB9-A073-AC531256A91FQ51363382-BC3A92C6-9E8E-452F-A196-0C7E3F3022C3Q57170632-57A4DD34-2AC0-48E0-B7FC-324A9A745C05Q59138135-CBFC8EEA-15C5-488A-8C89-166961B88F32
P2860
Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Monitoring of the biological r ...... positron emission tomography.
@ast
Monitoring of the biological r ...... positron emission tomography.
@en
Monitoring of the biological r ...... positron emission tomography.
@nl
type
label
Monitoring of the biological r ...... positron emission tomography.
@ast
Monitoring of the biological r ...... positron emission tomography.
@en
Monitoring of the biological r ...... positron emission tomography.
@nl
prefLabel
Monitoring of the biological r ...... positron emission tomography.
@ast
Monitoring of the biological r ...... positron emission tomography.
@en
Monitoring of the biological r ...... positron emission tomography.
@nl
P2093
P2860
P1433
P1476
Monitoring of the biological r ...... positron emission tomography.
@en
P2093
David S Wang
Ian Y Chen
Jürgen K Willmann
Mark Rollins
Martin Rodriguez-Porcel
Olivier Gheysens
Ramasamy Paulmurugan
Sanjiv S Gambhir
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.733220
P407
P577
2008-02-04T00:00:00Z